rejuvant life tabs
rejuvant life tabs

Investment

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from...

Capsida Biotherapeutics emerges from stealth with $140m

Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...

Longevity investment: small sums behind big ideas

Sonia Arrison talks about her journey to becoming an early stage investor and what longevity means to her. While longevity is now seeing increasing interest...

Latest news

Longevity investment: small sums behind big ideas

Sonia Arrison talks about her journey to becoming an early stage investor and what longevity means to her. While longevity is now seeing increasing interest...

ChromaDex and H&H announce Niagen supply agreement

H&H Group expands Swisse healthy aging product line into growing NAD+ space with Niagen from ChromaDex. Los Angeles-based ChromaDex has announced it entered into a strategic...

Nesta and UKRI offer £6m for healthy aging start-ups

New partnership provides £6m in investment and grants to progress improved health in later life. Nesta – the UK’s innovation foundation for social good –...

Turn completes funding round for disruptive technologies

Silicon Valley investor Khosla Ventures joins esteemed group of global investors backing Turn Biotechnologies. Turn Biotechnologies, a company developing novel RNA medicines for untreatable age-related...

Longevity supplements report: Longevity Labs+

Longevity Labs+ – translating scientific findings into natural solutions so people can live longer, healthier lives with spermidineLIFE. Over the coming weeks, we will be...

Building a longevity biotech from scratch

Alchemab exec talks company creation and how antibody therapeutics may play a role in longevity biotech. Last week, we covered Alchemab Therapeutics’ $82 million Series...

Edifice raises $12m to change the course of aging

Edifice Health seeks to reinvent immune health and improve healthspan with $12m investment led by Leaps by Bayer. Stanford spin-out Edifice Health, a Silicon Valley...

Rejuvenate Bio bags $10m to develop gene therapy for aging

San Diego-based start-up raises over $10m in series A funding and will use gene therapy, proprietary targets and the animal health market to commercialise...

Longevity supplements report: Hydra Longevity profile

Hydra Longevity – bringing a 'whole plant' approach to healthy aging supplements. Over the coming weeks, we will be bringing you extracts of 11 company...
Rejuvant
Supps report ad middle

Longevity investment firm announces acceleration programme

Call for future founders: longevity investment fund LongeVC announces in-house acceleration programme. LongeVC – a longevity investment group backed by an advisory board with solid...

Longevity supplements report: Seneque profile

Seneque's supplement Elevant Prime seeks to promote vitality by recharging energy, repairing cells and rewinding age. Over the coming weeks, we will be bringing you...

Juvenescence debuts ketosis longevity supplement drink

Biotech Juvenescence's new product Metabolic Switch is a drink that supports healthy aging and a healthy metabolism by generating a state of ketosis. It's been...

AXA and Microsoft launch one-stop digital health platform

Microsoft joins forces with AXA for ‘one-stop’ digital healthcare platform. One of Europe's leading insurance companies AXA has announced it has formed a partnership with...

Most popular

Cutting longevity drugs development from 15 years to one

Celeris bags €400k for creation of deep learning platform to support development of longevity drugs for Alzheimer's and other age-related diseases. With a focus on...

Longevity companies to watch in 2021

As the world enters the new year with a vaccine and an increased focus on geroprotection, there’s much to look forward to. Research from the...

Longevity investing has “come of age” says MMC founder

McKenny-McFarlane Capital is focused on bridging the communication gap between longevity investing and longevity companies. An investment firm with its sights firmly locked on longevity...

Nerve regeneration tech targets Alzheimer’s and Nasdaq

NervGen readies for NASDAQ listing and clinical trials of lead compound for nerve regeneration in 2021. With a unique nerve regeneration technology, Canadian biotech NervGen...
Supplement report

You might also like

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...

Capsida Biotherapeutics emerges from stealth with $140m

Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...

Longevity supplements report: Vitalic

Currently in stealth, Vitalic is on a mission to transition longevity from the early adopters on to a mass market through best-in-class marketing. Over the...
Supps report ad middle